Recently, LEGALBAND, a renowned legal rating agency, released its list of 2020 China Top 15 Lawyers – New Economy, Mr. LI Qiang, director and managing partner of Grandall Shanghai was honored the award.

Mr. LI has extensive experience in the fields of domestic and overseas Offering, M&A, investment and financing, foreign investment and trusts, and has acted as perennial advisor for dozens of commercial banks, investment banks, state-owned investment companies, foreign-invested enterprises, private companies and listed companies.

LI Qiang now acts as director and managing partner of Grandall Shanghai Office, director of Securities Committee of Shanghai Bar Association, arbitrator of Shanghai Arbitration commission, guest professor of Fudan University, East China University of Political Science and Law, and Shanghai University of International Business and Economics.  He mainly practices in the capital markets, covering private equity investment, corporate listing, mergers, acquisitions and restructuring in the biomedicine, semiconductor, TMT and other industries.  Mr. LI has provided legal service in raising, establishment and investment of dozens of private funds, such as Softbank China, Walden International, Honghui Fund, Lingang Fund, Guokai Oriza, Guohe Fund, and Cenova Ventures, and assisted numerous companies in their respective domestic and overseas offering and reorganization, including without limitation, China Grand Automotive Services Group Co., Ltd., Risen Energy Co., Ltd., Touchstone International Medical Science Co., Ltd., Swancor Advanced Materials Co., Ltd., Shanghai Gentech Co., Ltd., 3peak Incorporated, Nantong Haixing Electronics Co., Ltd., Ganso Co., Ltd., Winner Technology Co., Inc., Fujian Cosunter Pharmaceutical Co., Ltd., Thalys Medical Technology Group Inc. and Omh Science Group Co., Ltd.